StockEdge: Stock Analysis, Screening & Research Platform for India
Depends
Confidence: Low
Active Indian retail traders who do daily EOD research fit this well . scans, F&O analytics, and Edge reports are the draw.
Comparison
StockEdge: Stock Analysis, Screening & Research Platform for India lands on Depends, and TradingView lands on Worth it.
Active Indian retail traders who do daily EOD research fit this well . scans, F&O analytics, and Edge reports are the draw.
If you actively trade and want the best-in-class charts, start on the free tier and upgrade only when you hit limits.
| Compare | StockEdge: Stock Analysis, Screening & Research Platform for India | TradingView |
|---|---|---|
| Verdict | Depends | Worth it |
| Best for | Active Indian stock traders | Active day and swing traders |
| Who it's not for | Passive index-fund investors . a screener is overkill | Buy-and-hold investors who check quotes monthly . massive overkill |
| Privacy | No known public vulnerabilities found in the sources reviewed.² | Runs a public bug bounty; one 2025 CVE in the Desktop app; recurring user reports of account compromise.⁹ |
| Support quality | No support evidence in sources reviewed. | No support-quality evidence in sources reviewed |
| Public sentiment | Praise for scans and derivative analytics exists, but every quote is vendor-published with no independent sources.¹ | Ratings are strong, but power users gripe about price creep and occasional chart freezing.³ |
| Biggest gotcha | Pricing not visible on reviewed pages; confirm plan costs in-app before subscribing.¹ | Free plan gates indicators and alerts; serious analysis pushes you into paid tiers⁵ |